Follow
Peto Tunde
Peto Tunde
Professor of Clinical Ophthalmology, Queen's University Belfast
Verified email at qub.ac.uk
Title
Cited by
Cited by
Year
Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ...
The Lancet Global Health 5 (12), e1221-e1234, 2017
29912017
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ...
The Lancet Global Health 5 (9), e888-e897, 2017
24362017
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis …
JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ...
The Lancet Global Health 9 (2), e144-e160, 2021
12162021
The epidemiology of age-related macular degeneration
R Klein, T Peto, A Bird, MR Vannewkirk
American journal of ophthalmology 137 (3), 486-495, 2004
12052004
The lancet global health commission on global eye health: vision beyond 2020
MJ Burton, J Ramke, AP Marques, RRA Bourne, N Congdon, I Jones, ...
The Lancet Global Health 9 (4), e489-e551, 2021
7772021
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study): 12-month data: report 2
M Michaelides, A Kaines, RD Hamilton, S Fraser-Bell, R Rajendram, ...
Ophthalmology 117 (6), 1078-1086. e2, 2010
7012010
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
R Bourne, JD Steinmetz, S Flaxman, PS Briant, HR Taylor, S Resnikoff, ...
The Lancet global health 9 (2), e130-e143, 2021
6142021
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3
R Rajendram, S Fraser-Bell, A Kaines, M Michaelides, RD Hamilton, ...
Archives of ophthalmology 130 (8), 972-979, 2012
5212012
Prevalence of age-related macular degeneration in Europe: the past and the future
JM Colijn, GHS Buitendijk, E Prokofyeva, D Alves, ML Cachulo, ...
Ophthalmology 124 (12), 1753-1763, 2017
5072017
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
4562021
Macular telangiectasia type 2
PC Issa, MC Gillies, EY Chew, AC Bird, TFC Heeren, T Peto, FG Holz, ...
Progress in retinal and eye research 34, 49-77, 2013
3822013
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 …
S Sivaprasad, AT Prevost, JC Vasconcelos, A Riddell, C Murphy, J Kelly, ...
The Lancet 389 (10085), 2193-2203, 2017
3792017
Screening for diabetic retinopathy: new perspectives and challenges
S Vujosevic, SJ Aldington, P Silva, C Hernández, P Scanlon, T Peto, ...
The Lancet Diabetes & Endocrinology 8 (4), 337-347, 2020
3522020
Diabetic retinopathy: pathogenesis, clinical grading, management and future developments
LZ Heng, O Comyn, T Peto, C Tadros, E Ng, S Sivaprasad, PG Hykin
Diabetic Medicine 30 (6), 640-650, 2013
3402013
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections
RRA Bourne, JB Jonas, AM Bron, MV Cicinelli, A Das, SR Flaxman, ...
British Journal of Ophthalmology 102 (5), 575-585, 2018
2952018
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
2772022
Redefining the overtraining syndrome as the unexplained underperformance syndrome
R Budgett, E Newsholme, M Lehmann, C Sharp, D Jones, T Jones, T Peto, ...
British Journal of Sports Medicine 34 (1), 67-68, 2000
2382000
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …
CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...
The Lancet 399 (10326), 741-755, 2022
2282022
Promising artificial intelligence-machine learning-deep learning algorithms in ophthalmology
L Balyen, T Peto
The Asia-Pacific Journal of Ophthalmology 8 (3), 264-272, 2019
2232019
Combining algorithms for automatic detection of optic disc and macula in fundus images
RJ Qureshi, L Kovacs, B Harangi, B Nagy, T Peto, A Hajdu
Computer Vision and Image Understanding 116 (1), 138-145, 2012
1902012
The system can't perform the operation now. Try again later.
Articles 1–20